Select a Size
About This Item
Product Name
Betamethasone sodium phosphate, United States Pharmacopeia (USP) Reference Standard
InChI
1S/C22H30FO8P.2Na/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30;;/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30);;/q;2*+1/p-2/t12-,15-,16-,17-,19-,20-,21-,22-;;/m0../s1
SMILES string
[Na+].[Na+].[H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1(F)[C@@H](O)C[C@@]4(C)[C@@]2([H])C[C@H](C)[C@]4(O)C(=O)COP([O-])([O-])=O
InChI key
PLCQGRYPOISRTQ-LWCNAHDDSA-L
grade
pharmaceutical primary standard
API family
betamethasone
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
Gene Information
human ... NR3C1(2908)
Looking for similar products? Visit Product Comparison Guide
Analysis Note
Application
Also used to prepare standard and system suitability solution during the assay and identification by using liquid chromatography in conjunction with UV detector according to the given below monographs of United States Pharmacopeia (USP):
- Dexamethasone Sodium Phosphate
- Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension
- Betamethasone Sodium Phosphate
- Betamethasone Sodium Phosphate Injection
General description
Other Notes
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Repr. 1B - STOT RE 2
target_organs
Liver,Kidney,Endocrine system
Storage Class
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
